Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 53 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT06524544
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Locally Advanced Urothelial Carcinoma, +5 more
- Locations
-
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
- UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
NCT06439836
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Metastatic Urothelial Carcinoma, +4 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
NCT05269381
- Conditions
- Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +165 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
NCT07484022
- Conditions
- Advanced Urothelial Cancer, Carcinoma, Carcinoma, Transitional Cell, +7 more
- Locations
-
- City of Hope Duarte, California, United States
- COH Lennar Irvine, California, United States
- Orlando Health Orlando, Florida, United States
- COH Atlanta Tucker, Georgia, United States
NCT06265285
- Conditions
- Adenocarcinoma, Advanced Esophageal Squamous Cell Carcinoma, Advanced Renal Cell Carcinoma, +81 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT07390617
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Metastatic Urothelial Carcinoma, +5 more
- Locations
-
- Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
NCT06862219
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Metastatic Urothelial Carcinoma, +3 more
- Locations
-
- Site IN91013 Patna, Bihar, India
- Site IN91015 Kochi, Kerala, India
- Site IN91004 Mumbai, Maharashtra, India
- Site IN91016 New Delhi, National Capital Territory of Delhi, India
NCT04878029
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation, +6 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
NCT04693377
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +66 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT07492628
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
NCT07221942
- Conditions
- Advanced Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +5 more
- Locations
-
- Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
NCT04623502
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +29 more
- Locations
-
- University of Texas Southwestern Medical Center Dallas, Texas, United States
Criteria for Selecting First-line Metastatic Treatment for Patients With Urothelial Carcinoma
NCT07339878
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Metastatic Urothelial Carcinoma, +3 more
- Locations
-
- Service Oncologie Médicale - CHU de Strasbourg - France Strasbourg, France
NCT04724018
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT05107674
- Conditions
- Adenoma, Adnexal Diseases, Breast Diseases, +75 more
- Locations
-
- City of Hope Duarte, California, United States
- University of Southern California Los Angeles, California, United States
- University of California, San Francisco San Francisco, California, United States
- University of Colorado School of Medicine Aurora, Colorado, United States
NCT06493552
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Metastatic Urothelial Carcinoma, +4 more
- Locations
-
- Sarcoma Oncology Center Santa Monica, California, United States
NCT04641936
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Metastatic Urothelial Carcinoma, +3 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
NCT05733000
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +67 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC
NCT07671092
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +21 more
- Locations
-
- Research Facility Christchurch, New Zealand
Sacituzumab Tirumotecan vs MMAE-ADCs in Advanced Urothelial Carcinoma (FUSCC-SPARE-UC-01)
NCT07662863
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +19 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China